Efficacy of chemoradiotherapy in pediatric H3K27M-mutant diffuse intrinsic pontine glioma: a study based on single-center and SEER data - Scorecard - MDSpire

Efficacy of chemoradiotherapy in pediatric H3K27M-mutant diffuse intrinsic pontine glioma: a study based on single-center and SEER data

  • By

  • Dandan Wang

  • Xiaohao Liu

  • Juan Wang

  • Boya Zhang

  • Suna Zhai

  • Jiayao Xu

  • Long Wang

  • Yingjuan Zheng

  • Wei Wei

  • Yubing Zhou

  • May 30, 2026

  • 0 min

Share

Clinical Scorecard: Effectiveness of Chemoradiotherapy for Pediatric H3K27M-Mutant Diffuse Intrinsic Pontine Glioma: Insights from a Single-Center and SEER Analysis

At a Glance

CategoryDetail
Condition
Key MechanismsH3K27M mutation reduces H3K27 trimethylation, driving tumor proliferation and resistance to treatment; consider adding implications for treatment strategies.
Target Population
Care Setting

Key Highlights

  • additional_statistics

Guideline-Based Recommendations

Diagnosis

    Management

    • E
    • x
    • p
    • a
    • n
    • d
    • t
    • o
    • i
    • n
    • c
    • l
    • u
    • d
    • e
    • a
    • d
    • d
    • i
    • t
    • i
    • o
    • n
    • a
    • l
    • m
    • a
    • n
    • a
    • g
    • e
    • m
    • e
    • n
    • t
    • s
    • t
    • r
    • a
    • t
    • e
    • g
    • i
    • e
    • s
    • a
    • n
    • d
    • c
    • o
    • n
    • s
    • i
    • d
    • e
    • r
    • a
    • t
    • i
    • o
    • n
    • s
    • f
    • o
    • r
    • t
    • r
    • e
    • a
    • t
    • m
    • e
    • n
    • t
    • .

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Clarify the context and evidence supporting the efficacy of TMZ in treatment regimens.

        Clinical Best Practices

        • monitoring

        Related Resources & Content

        Original Source(s)

        Related Content